Atlas Trials

Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product

Clinical trial NCT05250141 · COMPLETED

Trial details

NCT number
NCT05250141
Sponsor
Laboratorios Andromaco S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2022-02-14
Primary completion
2022-02-17
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.